The effect of proliferative hypertrophic scars on determining treatment options for preventing recurrence of vesicourethral anastomotic stenosis after radical prostatectomy: a single-center cross-sectional study

ABSTRACT BACKGROUND: Vesicourethral anastomotic stenosis (VUAS) following retropubic radical prostatectomy (RRP) significantly worsens quality of life. OBJECTIVES: To investigate the relationship between proliferative hypertrophic scar formation and VUAS, and predict more appropriate surgical intervention for preventing recurrent VUAS. DESIGN AND SETTING: Retrospective cross-sectional single-center study on data covering January 2009 to December 2019. METHODS: Among 573 male patients who underwent RRP due to prostate cancer, 80 with VUAS were included. They were divided into two groups according to VUAS treatment method: dilatation using Amplatz renal dilators (39 patients); or endoscopic bladder neck incision/resection (41 patients). The Vancouver scar scale (VSS) was used to evaluate the characteristics of scars that occurred for any reason before development of VUAS. RESULTS: Over a median follow-up of 72 months (range 12-105) after RRP, 17 patients (21.3%) had recurrence of VUAS. Although the treatment success rates were similar (79.5% versus 78.0%; P = 0.875), receiver operating characteristic (ROC) curve analysis indicated that dilatation using Amplatz dilators rather than endoscopic bladder neck incision/resection in patients with VSS scores 4, 5 and 6 may significantly reduce VUAS recurrence. A strong positive relationship was observed between VSS and total number of VUAS occurrences (r: 0.689; P < 0.001). VSS score (odds ratio, OR: 5.380; P < 0.001) and time until occurrence of VUAS (OR: 1.628; P = 0.008) were the most significant predictors for VUAS recurrence. CONCLUSIONS: VSS score can be used as a prediction tool for choosing more appropriate surgical intervention, for preventing recurrent VUAS.

Perioperatorio y recurrencia oncológica: reto actual en la práctica anestésica / Perioperative and cancer relapse: a challenge in current anesthetic practice

Introducción: El cáncer es la segunda causa de muerte en el mundo y en Cuba. Su estrategia de tratamiento implica fármacos oncoespecíficos y cirugía; y diariamente aumentan los pacientes intervenidos quirúrgicamente lo que conlleva a un periodo perioperatorio y la administración de múltiples medicamentos anestésicos. Objetivo: Describir los principales factores relacionados con la anestesia que, durante el perioperatorio, influyen en la recurrencia oncológica. Desarrollo: El estrés quirúrgico y la anestesia general, con la subsecuente respuesta neuroendocrina e inflamatoria, por sí mismos, limitan la respuesta inmune y alteran el balance entre el potencial metastásico del tumor y antimetastásico de las defensas, lo cual representa un mecanismo plausible en el incremento de las metástasis y recurrencia oncológica. Conclusiones: La proliferación del cáncer y recidiva tumoral en el contexto quirúrgico asociado a la anestesia, es un tema relativamente nuevo y por tanto es necesario realizar estudios con mayor alcance que validen este fenómeno. No obstante, el efecto inmunosupresor que produce el estrés perioperatorio, fármacos anestésicos como opioides y halogenados pueden ser la clave para explicar este fenómeno. La anestesia general endovenosa total libre de opioides y adecuada analgesia regional contribuyen a disminuir este efecto(AU)

Introduction: Cancer is the second cause of death worldwide and in Cuba. Its treatment strategy involves oncospecific drugs and surgery. Every day, the number of patients who undergo surgery increases, which leads to a perioperative period and the administration of multiple anesthetic medications. Objective: To describe the main factors related to anesthesia and that, during the perioperative period, influence oncological recurrence. Development: Surgical stress and general anesthesia, with the subsequent neuroendocrine and inflammatory response, by themselves, limit the immune response and alter the balance between the metastatic potential of the tumor and the antimetastatic defense, which represents a plausible mechanism for increased metastasis and oncological relapse. Conclusions: The proliferation of cancer and tumor relapse in the surgical context associated with anesthesia is a relatively new issue and it is therefore necessary to carry out studies with greater scope that validate this phenomenon. However, the immunosuppressive effect produced by perioperative stress, as well as anesthetic drugs such as opioids and halogenated drugs, can be the key to explaining this phenomenon. Total intravenous opioid-free general anesthesia and adequate regional analgesia contribute to diminish this effect(AU)

Cirugía transoral en cáncer de laringe estadificado T1-T2 / Transoral surgery in T1-T2 staged laryngeal cancer

Se realizó un estudio prospectivo y descriptivo, incluyendo 103 pacientes que fueron tratados por cáncer de laringe en etapa inicial (T1-T2) con cirugía transoral. De ellos, 55 se diagnosticaron en estadio T1, 16 en estadio T1-b y 32 en estadio T2. El control local inicial (CLI) en pacientes con tumores malignos de laringe estadificados T1 fue 91%, el control local con rescate (CLR) 96%, la preservación de la función de la laringe (PFL) 93% y la sobrevida específica 96%. En T1-b, el CLI fue 81%, el CLR 94%, la PFL 94% y la sobrevida específica 94%. En T2, el CLI fue 63%, el CLR 94%, la PFL 72% y la sobrevida específica 78%. La cirugía transoral en cáncer de laringe con T inicial tiene resultados oncológicos similares a otros tratamientos (cirugía externa o radioterapia), pero consideramos que es la mejor opción por su baja morbilidad, menor duración del tratamiento, y porque deja abiertas todas las posibilidades para tratar posibles recurrencias. (AU)

A prospective and descriptive study was conducted, including 103 patients who were treated for early stage laryngeal cancer (T1-T2) with transoral surgery. Of these, 55 were diagnosed in stage T1, 16 in stage T1-b and 32 in stage T2. The initial local control (CLI) in patients with malignant T1 laryngeal tumors was: 91%, local control with rescue (CLR) 96%, preservation of larynx function (PFL) 93% and specific survival 96%. In T1-b the CLI was 81%, the CLR 94%, the PFL 94% and the specific survival 94%. In T2 the CLI was 63%, the CLR 94%, the PFL 72% and the specific survival 78%. Transoral surgery in laryngeal cancer with initial T has oncological results similar to other treatments (external surgery or radiotherapy), but we consider that it is the best option because of its low morbidity, shorter duration of treatment, and because it leaves open all the possibilities to treat possible recurrences. (AU)

Adenocarcinoma de células basales / Basal cell adenocarcinoma

El adenocarcinoma de células basales, también conocido como carcinoma salival basaloide, adenoma maligno de células basales, es una neoplasia epitelial de bajo grado, infiltrante, localmente destructivo y con tendencia a ser recidivante. Su aparición es entre la 5ª y 6ª década de vida, sin predilección por sexo. Clínicamente se manifiesta con un edema o un aumento repentino de tamaño en la zona, de consistencia firme, crecimiento lento e indoloro. El diagnóstico de certeza es a través de la histopatología; su tratamiento quirúrgico, y tiene buen pronóstico en sus estadios iniciales (AU)

Basal cells adenocarcinoma also known as salivary basaloide carcinoma basal cells malignant adenoma is a low degree, infiltrating, locally destructive and prone to be relapsing, epithelial neoplasia. It occurs between the 5th and 6th decade of life, with no predilection for sex. Clinically it manifests with an edema or sudden increased size in the area, of firm consistency, slow growth and pain-less. Its treatment is surgical and the diagnosis of certainty is histopathological with a good prognosis. The purpose of this presentation is to show the case of a 57- years-old male patient with clinical and anatomopathological diagnosis of adenocarcinoma of basal cells located in the yugal mucosa (AU)

Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis / Esvaziamento cervical central profilático e recidiva local de microcarcinoma papilífero de tireoide: uma metanálise

Abstract Introduction: For papillary thyroid microcarcinoma patients, the reported incidence of lymph node metastasis is as high as 40%, and these occur mainly in the central compartment of the neck. Because these metastases are difficult to detect using ultrasonography preoperatively, some authors advocate routine central neck dissection in papillary thyroid microcarcinoma patients at the time of initial thyroidectomy. Objective: To evaluate whether prophylactic central neck dissection can decrease the local recurrence rate of papillary thyroid microcarcinoma after thyroidectomy. Methods: The publicly available literature published from January 1990 to December 2017 concerning thyroidectomy plus prophylactic central neck dissection versus thyroidectomy for papillary thyroid microcarcinoma was retrieved by searching the national and international online databases. A meta-analysis was performed after the data extraction process. Results: Four studies were finally included with a total of 727 patients, of whom, 366 cases underwent thyroidectomy plus prophylactic central neck dissection and 361 cases received thyroidectomy only. As shown by the meta-analysis results, the recurrence rates in cases of thyroidectomy plus prophylactic central neck dissection were approximately 1.91% and were significantly lower than those with thyroidectomy only (OR = 0.24, 95% CI [0.10, 0.56], p = 0.0009). Conclusion: For patients with papillary thyroid microcarcinoma, thyroidectomy plus prophylactic central neck dissection is a safe and efficient procedure and it results in lower recurrence rate. Since the evidences are of low quality (non-randomized studies), further randomized trials are needed.

Resumo Introdução: A incidência relatada de metástases linfonodais chega a 40% em pacientes com microcarcinoma papilífero de tireoide e essas ocorrem principalmente no compartimento cervical central. Como essas metástases são difíceis de ser detectadas com o uso de ultrassonografia no pré-operatório, alguns autores defendem o esvaziamento cervical central de rotina em pacientes portadores de microcarcinoma papilífero de tireoide no momento da tireoidectomia inicial. Objetivo: Avaliar se o esvaziamento cervical central profilático pode diminuir a taxa de recorrência local de microcarcinoma papilífero de tireoide após a tireoidectomia. Método: A literatura disponível, publicada de janeiro de 1990 a dezembro de 2017, sobre tireoidectomia com esvaziamento cervical central profilático versus tireoidectomia somente para microcarcinoma papilífero de tireoide foi obtida através de busca nas bases de dados online nacionais e internacionais. A metanálise foi feita após o processo de extração de dados. Resultados: Quatro estudos foram finalmente incluídos na metanálise, com 727 pacientes, dos quais 366 foram submetidos à tireoidectomia com esvaziamento cervical central profilático e 361 só receberam tireoidectomia. Como mostrado pelos resultados da metanálise, as taxas de recorrência com tireoidectomia com esvaziamento cervical central profilático foram de 1,91% e foram significantemente menores do que aquelas em pacientes submetidos somente à tiroidectomia (OR = 0,24, IC95% [0,10-0,56], p = 0,0009). Conclusão: Para pacientes com microcarcinoma papilífero de tireoide, o esvaziamento cervical central profilático é um procedimento seguro e eficiente e resulta em menor taxa de recorrência. Como as evidências são de baixa qualidade (estudos não randomizados), mais estudos randomizados são necessários.

Schwannoma lumbosacro gigante / Schwannome lombo-sacré géant / Giant lumbosacral schwannoma

Fundamento: el schwannoma espinal es un tumor de las vainas nerviosas y se comporta intradural y extramedular y provienen de las células embrionarias de la cresta neural de los nervios periféricos. Representan entre el 25 y el 30 por ciento de los tumores y afectan a adultos entre 40 y 60, son raros en niños y no hay predilección por el sexo. Objetivo: presentar un caso de schwannoma lumbosacro gigante que se diagnosticó en el Hospital Universitario Manuel Ascunce Domenech de Camagüey y recibió tratamiento quirúrgico en el Instituto Nacional de Neurología y Neurocirugía. Reporte de caso: paciente MB, de 38 años con antecedentes de salud con historia de dolor lumbosacro de dos años de evolución, intensificado en los últimos 8 meses que se irradiaba a miembros inferiores con parestesias y pérdida de la fuerza muscular. Además presentaba dificultad para la deambulación, constipación, incontinencia urinaria y eyaculación retardada. La tomografía axial computarizada informó un extenso proceso tumoral intrarraquídeo con crecimiento longitudinal anterior, posterior y lateral desde la cuarta vértebra lumbar hasta la tercera sacra (L4-S3), que producía lisis de la porción posterior de los cuerpos vertebrales, los pedículos y el borde anterior de S3 y la imagen de resonancia magnética reveló gran área ligeramente hipointensa en T1 e hiperintensa en T2, que ocupaba el canal vertebral desde L3 hasta la cuarta vertebra sacra (S4). La biopsia informó un tumor constituido por células de aspecto fusocelular dispuesto en fascículos compactos, otras áreas más laxas compuestas por células de citoplasma claro, abundantes vasos sanguíneos, compatible con un schwannoma, tumor benigno de las vainas nerviosas. Se remitió para tratamiento quirúrgico en el Instituto Nacional de Neurología y Neurocirugía con evolución favorable luego de la resección amplia e instrumentación. Conclusiones: el schwannoma lumbosacro es un reto para los cirujanos y la afectación sacra es rara. El diagnóstico anatomopatológico es fundamental y la cirugía es el tratamiento de elección, donde la resección completa del tumor es muy difícil en ocasiones debido a la posibilidad de lesionar estructuras nerviosas importantes. Se recomienda el seguimiento radiológico por el riesgo de recidivas(AU)

Background: The spinal schwannoma is a tumor of the nerve sheaths that presents in intradural and extramedular areas. It comes from the embryonic cells of the neural crest of the peripheral nerves. They represent 25-30 percent of tumors and it affects adults aging 40 and 60. It is rare in children and there is no sex difference. Objective: Present a case of giant lumbosacral schwannoma that was diagnosed at Manuel Ascunce Domenech University Hospital in Camagüey. This patient received surgical treatment at the National Institute of Neurology and Neurosurgery. Case report: 38-year-old white male patient with a history of lumbosacral pain of two years of evolution came to consultation. His pain intensified in the last 8 months, radiating to lower limbs with paresthesias and loss of muscle strength. In addition, he had constipation, urinary incontinence, difficulty at walking, and delayed ejaculation. Computed tomography revealed an extensive intrarectal tumor process with anterior, posterior and lateral longitudinal growth from the fourth lumbar vertebra to the third sacrum (L4-S3), which produced lysis of the posterior portion of the vertebral bodies, pedicles, and S3 anterior border. Magnetic resonance imaging revealed a large area slightly hypointense in T1 and hyperintense in T2, which occupied the vertebral canal from L3 to the fourth sacral vertebra (S4). The biopsy reported a tumor-like fusocellular cells arranged in compact fascicles, other more lax areas of clear cytoplasm cells, abundant blood vessels, compatible with a schwannoma, benign tumor of the nerve sheaths. The patient was referred for surgical treatment at the National Institute of Neurology and Neurosurgery with favorable evolution after extensive resection and instrumentation. Conclusions: Lumbosacral schwannoma is a challenge for surgeons. Sacral involvement is rare. Histopathologic diagnosis is fundamental and surgery is the treatment of choice, in which complete resection of the tumor is very difficult at times due to the possibility of injuring important nerve structures. Radiological follow-up is recommended for the risk of relapses(AU)

Fondement: Le schwannome rachidien est une tumeur de comportement intradural et extramédullaire des gaines nerveuses, provenant des cellules embryonnaires de la crête neurale des nerfs périphériques. Il représente 25 à 30 pourcent des tumeurs, touchant généralement les adultes âgés de 40 à 60 ans. Chez l'enfant, il est rare. Il touche les deux sexes en égal. Objectif: Présenter un cas de schwannome lombo-sacré géant diagnostiqué à l'hôpital universitaire "Manuel Ascunce Domenech", à Camagüey, et traité chirurgicalement à l'Institut national de neurologie et neurochirurgie, à La Havane. Rapport de cas: Patient, blanc, âgé de 38 ans, ayant une histoire de douleur lombo-sacrée de deux ans d'évolution, intensifiée dans ces huit derniers mois et irradiée aux membres inférieurs avec paresthésie et perte de la force musculaire. Il avait aussi des difficultés pour la marche, et souffrait de constipation, incontinence urinaire et éjaculation retardée. La tomographie axiale calculée par ordinateur a montré un large processus tumoral intrarachidien, avec une croissance longitudinale antérieure, postérieure et latérale depuis la quatrième vertèbre lombaire jusqu'à la troisième sacrée (L4-S3), produisant la lyse de la portion postérieure des corps vertébraux, des pédicules et du bord antérieur de S3, et l'imagerie par résonance magnétique a révélé une vaste zone légèrement hypointense en T1 et hyperintense en T2, occupant le canal vertébral depuis L3 jusqu'à la quatrième vertèbre sacrée (S4). La biopsie a indiqué une tumeur constituée de cellules d'aspect fusocellulaire disposées en fascicules compacts, d'autres zones plus détendues composées de cellules à cytoplasme clair, beaucoup de vaisseaux sanguins, évoquant un schwannome, c.-à-d., une tumeur bénigne des gaines nerveuses. Le patient a été renvoyé vers l'Institut national de neurologie et neurochirurgie pour un traitement chirurgical. Après une grande résection et appareillage, son évolution a été favorable. Conclusions: Le schwannome lombo-sacré constitue un défi pour les chirurgiens parce que cette affection est très rare. Son diagnostic anatomopathologique est essentiel. L'intervention chirurgicale est le traitement de choix, mais la résection complète de la tumeur est parfois très difficile due à la proximité de structures nerveuses importantes. Il est conseillé un suivi radiologique de risque de récidive(AU)

Carcinoma of the cervix in elderly patients treated with radiotherapy: patterns of care and treatment outcomes / 부인종양

OBJECTIVE: The aim of this analysis was to examine the management of cervix cancer in elderly patients referred for radiotherapy and the results of treatment in terms of overall survival (OS), relapse-free survival (RFS), and treatment-related toxicities. METHODS: Patients were eligible if they were aged ≥75 years, newly diagnosed with cervix cancer and referred for radiotherapy as part of their treatment. Patient details were retrieved from the gynaecology service database where clinical, histopathological treatment and follow-up data were prospectively collected. RESULTS: From 1998 to 2010, 126 patients aged ≥75 years, met selection criteria. Median age was 81.5 years. Eighty-one patients had definitive radiotherapy, 10 received adjuvant radiotherapy and 35 had palliative radiotherapy. Seventy-one percent of patients had the International Federation of Gynecology and Obstetrics stage 1b–2b disease. Median follow-up was 37 months. OS and RFS at 3 years among those treated with curative intent were 66.6% and 75.9% respectively with majority of patients dying without any evidence of cervix cancer. Grade 2 or more late toxicities were: bladder 5%, bowel 11%, and vagina 27%. Eastern Cooperative Oncology Group (ECOG) status was a significant predictor of OS and RFS with each unit increment in ECOG score increased the risk of death by 1.69 times (p<0.001). CONCLUSION: Following appropriate patient selection, elderly patients treated curatively with radiotherapy for cervix cancer have good disease control. Palliative hypofractionated regimens are well tolerated in patients unsuitable for radical treatment.

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08) / 부인종양

OBJECTIVE: To investigate the role of radiotherapy (RT) in patients who underwent hysterectomy for uterine carcinosarcoma (UCS). METHODS: Patients with the International Federation of Gynecology and Obstetrics stage I–IVa UCS who were treated between 1990 and 2012 were identified retrospectively in a multi-institutional database. Of 235 identified patients, 97 (41.3%) received adjuvant RT. Twenty-two patients with a history of previous pelvic RT were analyzed separately. Survival outcomes were assessed using the Kaplan-Meier method and Cox proportional hazards model. RESULTS: Patients with a previous history of pelvic RT had poor survival outcomes, and 72.6% of these patients experienced locoregional recurrence; however, none received RT after a diagnosis of UCS. Univariate analyses revealed that pelvic lymphadenectomy (PLND) and para-aortic lymph node sampling were significant factors for locoregional recurrence-free survival (LRRFS) and disease-free survival (DFS). Among patients without previous pelvic RT, the percentage of locoregional failure was lower for those who received adjuvant RT than for those who did not (28.5% vs. 17.5%, p=0.107). Multivariate analysis revealed significant correlations between PLND and LRRFS, distant metastasis-free survival, and DFS. In subgroup analyses, RT significantly improved the 5-year LRRFS rate of patients who did not undergo PLND (52.7% vs. 18.7% for non-RT, p<0.001). CONCLUSION: Adjuvant RT decreased the risk of locoregional recurrence after hysterectomy for UCS, particularly in patients without surgical nodal staging. Given the poorer locoregional outcomes of patients previously subjected to pelvic RT, meticulous re-administration of RT might improve locoregional control while leading to less toxicity in these patients.

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives / 부인종양

Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma or endometrioid adenocarcinoma. To improve the survival of patients with ovarian CCC, the deeper understanding of the mechanism of CCC carcinogenesis as well as the efforts to develop novel treatment strategies in the setting of both front-line treatment and salvage treatment for recurrent disease are needed. In this presentation, we first summarize the mechanism responsible for carcinogenesis. Then, we highlight the promising therapeutic targets in ovarian CCC and provide information on the novel agents which inhibit these molecular targets. Moreover, we discuss on the cytotoxic anti-cancer agents that can be best combined with targeted agents in the treatment of ovarian CCC.

Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan / 부인종양

OBJECTIVE: Although radiation therapy (RT) and concurrent chemoradiotherapy (CCRT) are the global standards for adjuvant therapy treatment in cervical cancer, many Japanese institutions choose chemotherapy (CT) because of the low frequency of irreversible adverse events. In this study, we aimed to clarify the trends of adjuvant therapy for intermediate/high-risk cervical cancer after radical surgery in Japan. METHODS: A questionnaire survey was conducted by the Japanese Gynecologic Oncology Group to 186 authorized institutions active in the treatment of gynecologic cancer. RESULTS: Responses were obtained from 129 facilities. Adjuvant RT/CCRT and intensity-modulated RT were performed in 98 (76%) and 23 (18%) institutions, respectively. On the other hand, CT was chosen as an alternative in 93 institutions (72%). The most common regimen of CT, which was used in 66 institutions (51%), was a combination of cisplatin/carboplatin with paclitaxel. CT was considered an appropriate alternative option to RT/CCRT in patients with risk factors such as bulky tumors, lymph node metastasis, lymphovascular invasion, parametrial invasion, and stromal invasion. The risk of severe adverse events was considered to be lower for CT than for RT/CCRT in 109 institutions (84%). CONCLUSION: This survey revealed a variety of policies regarding adjuvant therapy among institutions. A clinical study to assess the efficacy or non-inferiority of adjuvant CT is warranted.

Granular Cell Tumors on Unusual Anatomic Locations

Granular cell tumors (GCTs) are soft tissue tumors, which are thought to be derived from Schwann cells. Although most GCTs are reported to arise in tongue and oral cavity (30-50%), they can appear on any anatomic sites, even visceral organs. Herein, we report 5 cases of GCTs on unusual anatomic locations, such as palm, arm, thigh, finger, and vulvar area. Complete surgical excision is preferred treatment of choice to prevent recurrence. These cases emphasize that GCTs not involving oral cavity are more prevalent than expected, and the diagnosis should be histopathologically confirmed.

Delayed postoperative radiation therapy in local control of squamous cell carcinoma of the tongue and floor of the mouth / Retardo da radioterapia pós-operatória no controle local do carcinoma epidermoide de língua e soalho de boca

Objective To evaluate the effect of time between surgery and postoperative radiation therapy on local recurrence of squamous cell carcinoma of the tongue and floor of the mouth. Methods A total of 154 patients treated between 1996 and 2007 were selected considering local recurrence rate and time of the adjuvant radiotherapy. Results Local recurrence was diagnosed in 54 (35%) patients. Radiation therapy reduced the rate of local recurrences, although with no statistical significance. The time between surgery and initiation of postoperative radiotherapy did not significantly influence the risk of local recurrence in patients referred to adjuvant treatment (p=0.49). Conclusion In the presence of risk factors for local recurrence, a short delay in starting the adjuvant radiation therapy does not contraindicate its performance. .

Objetivo Avaliar o efeito do tempo entre o tratamento cirúrgico e a radioterapia pós-operatória nas recidivas locais do carcinoma epidermoide de língua e soalho da boca. Métodos Foram selecionados 154 pacientes tratados entre 1996 e 2007, considerando a frequência das recidivas locais e o tempo para início da radioterapia adjuvante. Resultados As recidivas locais foram diagnosticadas em 54 (35%) pacientes. A radioterapia reduziu a frequência de recidivas locais, embora sem significância estatística. O tempo entre a cirurgia e o início da radioterapia pós-operatória não influenciaram, de forma significante, no risco de recidivas locais entre o pacientes que tinham indicação de tratamento adjuvante (p=0,49). Conclusão Na presença de fatores de risco para recidiva local, um pequeno atraso no início da radioterapia adjuvante não contra-indica sua realização. .

Complementação por coagulação com plasma de argônio após a ressecção endoscópica completa pela técnica de fatiamento para grandes adenomas colorretais / Complementation by argon plasma coagulation after endoscopic piecemeal resection of large colorectal adenomas

OBJETIVO: avaliar a eficácia da complementação por coagulação com plasma de argônio para reduzir a taxa de neoplasia residual ou recorrente após ressecção endoscópica completa fragmentada de grandes adenomas sésseis colorretais. MÉTODOS: critérios de inclusão: pacientes com grandes adenomas colorretais sésseis, > 20mm, sem sinais morfológicos de infiltração profunda, submetidos à ressecção endoscópica completa fragmentada estudada com cromoendoscopia e magnificação de imagens. Os pacientes foram randomizados em dois grupos: grupo 1 - nenhum procedimento adicional e, grupo 2 - complementação por coagulação com plasma de argônio. O seguimento por colonoscopia foi realizado em três, seis e 12 meses de pós-operatório. Foi avaliada a taxa de neoplasia residual ou recidiva local. RESULTADOS: foram incluídos no estudo um total de 21 lesões. Onze lesões no grupo 1 e dez no grupo 2. Ocorreram duas neoplasias residuais ou recorrências locais em cada grupo, detectadas em três meses de acompanhamento. CONCLUSÃO: a complementação por coagulação com plasma de argônio após uma aparente ressecção endoscópica completa em fragmentos de grandes adenomas sésseis colorretais não parece reduzir a ocorrência de lesão adenomatosa residual ou recidiva local.

OBJECTIVE: To evaluate the efficacy of complement by argon plasma coagulation to reduce the rate of residual or recurrent tumor after complete endoscopic piecemeal resection of large sessile colorectal adenomas. METHODS: Inclusion criteria: patients with large sessile colorectal adenomas (e" 20 mm), without morphological signs of deep infiltration, submitted to complete endoscopic piecemeal resection studied with chromoendoscopy and magnification of images. Patients were randomized into two groups: group 1 - no additional procedure, and group 2 - complementation by argon plasma coagulation. follow-up colonoscopy was performed at three, six and 12 months postoperatively. We evaluated the rate of local recurrence or residual malignancy. RESULTS: The study included 21 patients, eleven in group 1 and ten in group 2. There were two local recurrences or residual tumors in each group, detected at three months follow-up. CONCLUSION: Complementation by argon plasma coagulation after apparent complete endoscopic piecemeal resection of large sessile colorectal adenomas does not seem to reduce the occurrence of residual adenomatous lesions or local recurrence.

Correlação entre dados clínico-patológicos e margens cirúrgicas em pacientes com carcinoma epidermoide da cavidade oral / Correlation between clinical and pathological data and surgical margins in patients with squamous cell carcinoma of the oral cavity

Há décadas se conhece a importância de se obter margens livres de neoplasia quando da ressecção de neoplasias de boca. OBJETIVO: Correlacionar achados clínico-patológicos com status de margem cirúrgica em pacientes com carcinoma espinocelular da língua e do assoalho da boca. MÉTODO: Forma de estudo: Estudo de coorte histórico, com corte transversal, envolvendo todos os pacientes submetidos à ressecção de carcinomas espinocelulares da língua oral e assoalho bucal entre os anos de 2007 e 2011 pelo Serviço de Cirurgia de Cabeça e Pescoço da nossa Instituição. RESULTADOS: Foram incluídos 117 casos, sendo 68.3% dos tumores localizados na língua. A relação homem:mulher foi de 2.3:1 e a média de idade foi de 57,6 anos. Ao todo, 23,0% dos casos tiveram margens de ressecção livres e amplas, 60,6% exíguas e 16,2% comprometidas. Diâmetro tumoral e espessura apresentaram correlação com margens de ressecção, sendo os tumores de estádio T mais elevados mais propensos à ressecção com margem insatisfatória. Casos operados com margens livres e amplas tiveram seus tumores ressecados mais comumente com técnicas trans-orais. CONCLUSÕES: Evidenciamos correlação entre tumores de maior volume, tanto em diâmetro quanto em espessura, com margens de ressecção insatisfatórias. Técnicas cirúrgicas de maior complexidade não tiveram associação com melhores margens de ressecção.

The importance of having tumor-free margins when resecting oral neoplasms has been known for decades. OBJECTIVE: To correlate clinical and pathology data to surgical margin status in patients with squamous cell carcinoma of the tongue and floor of the mouth. METHOD: This historical cohort cross-sectional study included all patients submitted to squamous cell carcinoma resection for tumors of the oral tongue and floor of the mouth between 2007 and 2011 at the Head and Neck Surgery service of our institution. RESULTS: In the 117 cases included, 68.3% had tongue tumors. The male-to-female ratio was 2.3:1 and patient mean age was 57.6 years. Broad free resection margins were seen in 23.0% of the cases; narrow margins in 60.6% of the cases; and compromised margins in 16.2%. Tumor diameter and thickness were correlated to resection margins. Tumors in more advanced T-stages presented more unsatisfactory margins. Patients operated with broad free margins had their tumors resected more commonly through transoral approaches. CONCLUSIONS: Tumors of larger volume both in terms of diameter and thickness were more correlated to unsatisfactory resection margins. Higher complexity procedures were not associated with better resection margins.

Imnunosupresión tras el trasplante hepático: más nefrones, menos hepatocarcinoma / Immunosupression after liver transplant: more nephrons, less hepatocellular carcinoma

Following liver transplantation, immunosuppressive drugs are responsible for a significant proportion of the morbidity and mortality. Thus, renal failure and hepatocellular carcinoma recurrence are critically related to the use of immunosuppressive drugs. In this article, the immunosuppressive strategies that allow preservation of the renal function and minimization of the recurrence rate of hepatocellular carcinoma are detailed.

Tras el trasplante hepático, la inmunosupresión es responsable de buena parte de la morbi-mortalidad asociada. El deterioro de la función renal y la recurrencia del hepatocarcinoma son ámbitos donde la inmunosupresión tiene un impacto significativo. En el presente artículo se abordan las estrategias inmunosupresoras que permiten preservar la función renal y minimizar la recurrencia del hepatocarcinoma tras el trasplante hepático.